Tech Company M&A Transactions
Akarna Therapeutics Acquisition
Based in Encinitas, Akarna Therapeutics was purchased by Allergan Plc. Purchase price was estimated to be $50 million.
Transaction Overview
Company Name
Acquired By
Announced On
9/21/2016
Transaction Type
M&A
Amount
$50,000,000
M&A Terms
Under the terms of the agreement, Allergan acquired Akarna for an upfront cash payment of $50 million and success-based development, regulatory and sales milestones.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1012 Second St. 210
Encinitas, CA 92007
USA
Encinitas, CA 92007
USA
Phone
Undisclosed
Website
Email Address
Overview
Akarna Therapeutics is a biopharmaceutical company developing novel small molecule therapeutics that target inflammatory and fibrotic diseases for which there is no approved treatment.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Raju Mohan
Browse more venture capital transactions:
Prev: 9/21/2016: Vroom venture capital transaction
Next: 9/21/2016: Cornami venture capital transaction
Share this article
About Database of VC Transactions
We report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs